Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy Sells 2,604 Shares

Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $70.45 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm’s 50 day moving average is $74.83 and its two-hundred day moving average is $72.61. The firm has a market capitalization of $8.75 billion, a P/E ratio of 28.99, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period last year, the firm earned $0.66 EPS. The company’s quarterly revenue was up 5.8% on a year-over-year basis. Research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Hedge Funds Weigh In On Henry Schein

A number of large investors have recently bought and sold shares of HSIC. Nuance Investments LLC lifted its position in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the period. Olstein Capital Management L.P. lifted its holdings in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after acquiring an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Henry Schein during the third quarter worth about $515,000. Private Management Group Inc. grew its holdings in shares of Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after acquiring an additional 18,882 shares during the period. Finally, Equitable Trust Co. acquired a new stake in Henry Schein in the fourth quarter valued at $417,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of several research reports. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group lowered their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.